New York, NY, United States of America

Olaf Schneewind

This inventor holds 3 USPTO granted patents. Top assignee: The Rockefeller University. Active years: 1997-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olaf Schneewind. Retrieved from https://idiyas.com/inventor/olaf-schneewind-3zuna8z6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 1997-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Olaf Schneewind

Introduction

Olaf Schneewind is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of microbiology, particularly in the development of hybrid surface proteins on bacteria. With a total of 3 patents, his work has implications for vaccines and diagnostic reagents.

Latest Patents

Schneewind's latest patents include innovative processes for the delivery and expression of hybrid surface proteins on the surface of gram-positive bacteria. One of his patents describes a method for transforming bacteria to express these proteins, which can be utilized as vaccines and for delivering active peptides to animal hosts. Another patent outlines a similar process, emphasizing the versatility of transformed bacteria in various applications, including diagnostics.

Career Highlights

Olaf Schneewind is affiliated with The Rockefeller University, where he conducts his research. His work has garnered attention for its potential to revolutionize vaccine development and improve diagnostic methods in medicine.

Collaborations

Some of his notable coworkers include Vincent A. Fischetti and Gianni Pozzi, who have collaborated with him on various research projects.

Conclusion

Olaf Schneewind's contributions to the field of microbiology through his patents and research at The Rockefeller University highlight the importance of innovation in developing new medical technologies. His work continues to pave the way for advancements in vaccine and diagnostic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…